Continuous Renal Replacement Therapy (CRRT) Circuit Troubleshooting Framework
CRRT circuit problems are most commonly caused by catheter dysfunction, line occlusion or malposition, filter/circuit clotting, or insufficient delivered dose from treatment interruptions (downtime). [1,2] Pressure alarms should be addressed by isolating the affected pressure variable and correcting circuit flow resistance before restarting blood flow. [2] Delivered dose should be evaluated using the prescribed versus delivered effluent (and downtime) to ensure achievement of guideline-recommended intensity. [3,4]
Catheter Placement and Access Configuration
Temporary dialysis catheter placement should preferentially be in the right internal jugular vein, then femoral vein, then left internal jugular vein, with subclavian veins as a last resort. [1] Catheter function should be assessed by pressure trends because access and return pressures reflect catheter patency and outflow resistance. [2] If access pressure is low (arterial lumen), blood flow resistance should be reduced by checking for catheter/line obstruction (kink, clot), malposition, and patient positioning, then considering lumen reversal if unresolved (noting increased recirculation risk). [2] If return pressure is high (venous lumen), venous outflow resistance should be reduced by checking for catheter/line obstruction (kink, clot), malposition, and patient positioning, then considering lumen reversal if unresolved. [2]
Pressure Alarm Interpretation and Corrective Actions
CRRT pressure alarms generally reflect one or more circuit pressures being outside the programmed range. [2] Persistent uncorrected pressure abnormalities can progress to blood pump stop. [2]
Low Access (Arterial Lumen) Pressure
Low access pressure should prompt verification that blood flow rate is not set higher than the circuit can support. [2] Low access pressure should prompt evaluation for high resistance between patient and blood pump due to catheter/line obstruction (kink or clot), patient positioning, or catheter malposition. [2] Clots in either lumen should be aspirated if identified by protocol, then catheter position should be reassessed. [2] If still unresolved, lumen reversal can be performed with awareness of increased recirculation. [2]
High Return (Venous Lumen) Pressure
High return pressure should prompt evaluation for venous outflow resistance due to catheter/line obstruction (kink or clot), patient positioning, or catheter malposition. [2] If still unresolved, lumen reversal can be considered. [2]
High Filter Pressure and TMP Escalation
High filter pressure should prompt identification of whether the return pressure is also high. [2] If return pressure is also high, the likely problem should be localized to the return limb of the circuit rather than the filter. [2] If only filter pressure is high, the likely problem should be localized to the filter. [2]
Rapid TMP rise should prompt immediate assessment for dialysate line obstruction (clamp or kink) and excessive ultrafiltration relative to blood flow rate. [2] Rapid TMP rise should also prompt assessment for replacement fluid rate being too high for the filter size. [2]
Gradual TMP rise should prompt evaluation for filter clogging versus clotting based on whether filter pressure drop increases. [2] Gradual TMP rise without increased filter pressure drop should be managed as filter clogging, including planning circuit replacement and increasing pre-filter fluid rate in CVVH. [2] Gradual TMP rise with increased filter pressure drop should be managed as filter or circuit clotting by optimizing anticoagulation, planning circuit replacement, increasing pre-filter fluid rate in CVVH, considering pre-dilution flush/rinsing, and optimizing filtration fraction. [2]
Anticoagulation Strategy for Circuit Patency
Anticoagulation should be used to maintain filter patency and optimize solute clearance by preventing circuit clotting. [5] Heparin anticoagulation protocols commonly include an initial bolus and weight-based maintenance infusion. [2] A heparin bolus of 2,000–2,500 units and a maintenance dose of 5–10 units/kg/hr are described in a CRRT management guideline protocol. [2] For patients at bleeding risk or contraindications to heparin, regional citrate anticoagulation is an alternative strategy with guideline-based protocol requirements. [6] Regional citrate anticoagulation recommendations are based on KDIGO-consistent practice and expert consensus protocols. [6]
Filter Clotting and Circuit Life Troubleshooting
Filter clotting should be suspected when TMP rises progressively and when filter pressure drop increases, suggesting clotting in the filter or circuit. [2] Clotting should be managed through optimization of anticoagulation and planning for circuit replacement when clot formation is extensive. [2] Rinsing or pre-dilution flush can be used as part of management when clotting is suspected but circuit function is still recoverable. [2] In CVVH, increasing pre-filter fluid rate is recommended as part of management for both filter clogging and clotting patterns. [2]
Delivered Dose and Achieved Intensity
Guideline-consistent CRRT dosing for AKI targets an average delivered effluent dose of 20–25 mL/kg/hr. [3] Dose adequacy should be assessed by verifying delivered effluent and documenting downtime because interruptions reduce delivered therapy. [3,4] Treatment interruptions and downtime should be tracked because they are a defined quality indicator for CRRT delivery. [4] Achieved delivered dose should be compared against the prescribed treatment plan to identify under-delivery driven by circuit downtime or frequent alarms. [4]
Common Pitfalls to Avoid
Frequent or prolonged pressure alarms without correction should be avoided because uncorrected pressure abnormalities can lead to blood pump stop and loss of delivered dose. [2] Incorrect fluid delivery settings (excess replacement fluid rate relative to filter size, excessive ultrafiltration relative to blood flow) should be avoided because these can precipitate rapid TMP rise. [2] Catheter malfunction due to line obstruction or malposition should be avoided because it promotes stasis of blood flow and subsequent clotting. [5]
Treatment Targets and Monitoring Priorities
A target of 20–25 mL/kg/hr delivered effluent should be used for CRRT intensity in AKI requiring continuous kidney replacement therapy. [3] Delivered dose should be monitored using both effluent prescription/delivery parameters and downtime documentation. [4] Catheter effectiveness should be monitored using access and return pressure trends because they reflect catheter patency and resistance to flow. [2] Filter performance should be monitored using TMP behavior and the presence or absence of increased filter pressure drop to differentiate clogging from clotting. [2]